Physical Therapy Center, Faculty of Physical Therapy, Mahidol University, Bangkok, 10700, Thailand.
Musculoskeletal Physical Therapy Research, Division of Physical Therapy, Faculty of Physical Therapy, Mahidol University, Nakhon Pathom, 73170, Thailand.
Lasers Med Sci. 2023 May 23;38(1):127. doi: 10.1007/s10103-023-03791-5.
This study aimed to compare the effects of radial extracorporeal shockwave therapy (rESWT) to the effects of high-intensity laser therapy (HILT) in the treatment of individuals with plantar fasciitis. Thirty-two individuals with unilateral plantar fasciitis were randomized into two groups: rESWT and HILT. In each group, the individuals underwent the intervention two sessions per week, for three weeks. Outcome measures included morning pain, resting pain, pain at 80 newtons (N) pressure, skin blood flow and temperature, plantar fascia (PF) and flexor digitorum brevis (FDB) thickness, and Foot Function Index (FFI). There was no significant difference in baseline characteristics of the individuals in both groups. All outcome measures, except skin blood flow and temperature, and FDB thickness, were significantly different (p < 0.05) over time. Skin blood flow was significantly different between groups at the end of the program. Either HILT or rESWT could alleviate pain in individuals with plantar fasciitis significantly. However, HILT was better at reducing FFI (functional limitation domain) rather than rESWT. This study was a randomized clinical trial and was approved by Mahidol University-Central Institutional Review Board (MU-CIRB) following the Declaration of Helsinki, COA no. MU_CIRB 2020/207.0412, the Thai Clinical Trials Registry (TDTR) numbered TCTR2021012500.
本研究旨在比较径向体外冲击波疗法（rESWT）与高强度激光疗法（HILT）治疗足底筋膜炎的效果。32 名单侧足底筋膜炎患者随机分为 rESWT 和 HILT 两组。每组患者每周接受两次干预，共三周。观察指标包括晨痛、静息痛、80 牛顿（N）压力下的疼痛、皮肤血流和温度、足底筋膜（PF）和趾短屈肌（FDB）厚度以及足功能指数（FFI）。两组患者的基线特征无显著差异。除皮肤血流和温度以及 FDB 厚度外，所有观察指标在时间上均有显著差异（p<0.05）。治疗结束时两组间皮肤血流有显著差异。HILT 或 rESWT 均可显著缓解足底筋膜炎患者的疼痛。然而，HILT 在降低 FFI（功能受限域）方面优于 rESWT。本研究为随机临床试验，符合《赫尔辛基宣言》，经玛希隆大学中央机构审查委员会（MU-CIRB）批准，注册号 MU_CIRB 2020/207.0412，泰国临床试验注册中心（TDTR）注册号 TCTR2021012500。
